Prognostic biomarkers based on melanoma cell-lines in stage III melanoma patients

被引：0
|
作者：
Knol, A. C. [1 ]
Nguyen, J. [1 ,2 ]
Pandolfino, M. [1 ,3 ]
Varey, E. [1 ,4 ]
Denis, M. G. [1 ,5 ]
Khammari, A. [1 ,4 ]
Dreno, B. [1 ,3 ,4 ]
机构：
[1] CHU Hotel Dieu, Lab Immunodermatol, CRCINA, Inserm U1232, Nantes, France
[2] SEME PHU11, Nantes, France
[3] UTCG, Nantes, France
[4] CHU Nantes, CIC, Serv Dermatol, Nantes, France
[5] Lab Biochim, Plateforme Genet Canc, Nantes, France
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 10期
关键词：
D O I：
10.1016/j.jid.2017.07.741
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
544
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [1] Identification of new prognostic biomarkers for Stage III metastatic melanoma patients
    Kakavand, Hojabr
    Scolyer, Richard A.
    Thompson, John F.
    Mann, Graham J.
    ONCOIMMUNOLOGY, 2013, 2 (09)
  • [2] Prognostic biomarkers in stage II-III melanoma.
    Rizk, Emanuelle M.
    Gartrell, Robyn D.
    Chen, Andrew
    Chang, Rui
    Marks, Douglas K.
    Esancy, Camden L.
    Taback, Bret
    Horst, Basil A.
    Drake, Charles G.
    Rabadan, Raul
    Saenger, Yvonne M.
    CANCER RESEARCH, 2020, 80 (19) : 49 - 50
  • [3] ABSENCE OF MELANOMA SPECIFICITY IN THE REACTIVITY OF MELANOMA PATIENTS SERA WITH CULTURED ALLOGENEIC MELANOMA CELL-LINES
    DENT, PB
    LIAO, SK
    MCCULLOCH, PB
    STONE, BR
    SINGAL, DP
    CANCER, 1982, 49 (10) : 2043 - 2048
  • [4] Prognostic variables for patients with stage III malignant melanoma
    Messaris, EG
    Konstadoulakis, MM
    Ricaniadis, N
    Leandros, E
    Androulakis, G
    Karakousis, CP
    EUROPEAN JOURNAL OF SURGERY, 2000, 166 (03) : 233 - 239
  • [5] Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
    Michael S. Sabel
    Jay Lee
    Shijie Cai
    Michael J. Englesbe
    Stephen Holcombe
    Stewart Wang
    Annals of Surgical Oncology, 2011, 18 : 3579 - 3585
  • [6] Stage-specific prognostic biomarkers in melanoma
    Cheng, Yabin
    Lu, Jing
    Chen, Guangdi
    Ardekani, Gholamreza Safaee
    Rotte, Anand
    Martinka, Magdalena
    Xu, Xuezhu
    McElwee, Kevin J.
    Zhang, Guohong
    Zhou, Youwen
    ONCOTARGET, 2015, 6 (06) : 4180 - 4189
  • [7] Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications
    Tonella, Luca
    Pala, Valentina
    Ponti, Renata
    Rubatto, Marco
    Gallo, Giuseppe
    Mastorino, Luca
    Avallone, Gianluca
    Merli, Martina
    Agostini, Andrea
    Fava, Paolo
    Bertero, Luca
    Senetta, Rebecca
    Osella-Abate, Simona
    Ribero, Simone
    Fierro, Maria Teresa
    Quaglino, Pietro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [8] Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
    Sabel, Michael S.
    Lee, Jay
    Cai, Shijie
    Englesbe, Michael J.
    Holcombe, Stephen
    Wang, Stewart
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (13) : 3579 - 3585
  • [9] Biomarkers in melanoma: Stage III and IV disease
    Linette, GP
    Carlson, JA
    Slominski, A
    Mihm, MC
    Ross, JS
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (01) : 65 - 74
  • [10] BIOLOGIC CHARACTERIZATION OF CANINE MELANOMA CELL-LINES
    WOLFE, LG
    OLIVER, JL
    SMITH, BB
    TOIVIOKINNUCAN, MA
    POWERS, RD
    BRAWNER, WR
    HENDERSON, RA
    HANKES, GH
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1987, 48 (11) : 1642 - 1648
12345